Literature DB >> 9379683

The effect of cytokines, including IL4, IL7, stem cell factor, insulin-like growth factor on childhood acute lymphoblastic leukemia.

R Consolini1, A Legitimo, M Cattani, P Simi, L Mattii, M Petrini, C Putti, G Basso.   

Abstract

We have investigated the effects of some interleukins, such as interleukin (IL) 4, IL7, stem cell factor (SCF) and insulin-like growth factor (IGF-1), known to be involved in human lymphopoiesis, on proliferation, clonal growth and differentiation of cells from two acute lymphoblastic leukemia (ALL) derived pre-B cell lines, that is, Nalm 1, Nalm 6 and purified blasts from 37 childhood ALL. IL4 did not display any promoting activity, an inhibitory effect being observed in two patients. IL7 showed an heterogeneous responsiveness, not related to immunophenotype or cytogenetic features, proliferation and clonal growth being observed in a minority of ALL. In other patients no or even inhibitory effects on proliferation were observed. In one case this inhibition of DNA synthesis was accompanied by maturation of the cells, as demonstrated by the induced expression of surface immunoglobulins (slg); other IL7 treated samples failed to express slg, but showed a decreased expression of terminal deoxynucleotidyl transferase and cALL antigen, suggesting that the cells have a potential of limited maturation by IL7. SCF, known to synergize with IL7 in the most primitive stages of normal B cell development, did not enhance the IL7 response in B cell precursor ALL. Finally IGF-1 failed to induce a proliferative response and clonal growth in BCP ALL either alone or in combination with IL7.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9379683     DOI: 10.1016/s0145-2126(97)00048-9

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


  4 in total

1.  Effects of vitamin D on the growth of normal and malignant B-cell progenitors.

Authors:  R Consolini; S Pala; A Legitimo; G Crimaldi; S Ferrari; S Ferrari
Journal:  Clin Exp Immunol       Date:  2001-11       Impact factor: 4.330

Review 2.  Interleukin-7 and interleukin-15 for cancer.

Authors:  Paul Zarogoulidis; Sofia Lampaki; Lonny Yarmus; Ioannis Kioumis; Georgia Pitsiou; Nikolaos Katsikogiannis; Wolfgang Hohenforst-Schmidt; Qiang Li; Haidong Huang; Antonios Sakkas; John Organtzis; Leonidas Sakkas; Ioannis Mpoukovinas; Kosmas Tsakiridis; George Lazaridis; Konstantinos Syrigos; Konstantinos Zarogoulidis
Journal:  J Cancer       Date:  2014-10-22       Impact factor: 4.207

3.  Defined, serum/feeder-free conditions for expansion and drug screening of primary B-acute lymphoblastic leukemia.

Authors:  Zhiwu Jiang; Di Wu; Wei Ye; Jianyu Weng; Peilong Lai; Pengcheng Shi; Xutao Guo; Guohua Huang; Qiuhua Deng; Yanlai Tang; Hongyu Zhao; Shuzhong Cui; Simiao Lin; Suna Wang; Baiheng Li; Qiting Wu; Yangqiu Li; Pentao Liu; Duanqing Pei; Xin Du; Yao Yao; Peng Li
Journal:  Oncotarget       Date:  2017-11-15

Review 4.  Pediatric precursor B acute lymphoblastic leukemia: are T helper cells the missing link in the infectious etiology theory?

Authors:  Simone Bürgler; David Nadal
Journal:  Mol Cell Pediatr       Date:  2017-05-16
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.